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Repetitive transcranial magnetic stimulation (rTMS) is primarily used in humans to
change the state of corticospinal excitability. To assess the efficacy of different rTMS
stimulation protocols, motor evoked potentials (MEPs) are used as a readout due to
their non-invasive nature. Stimulation of the motor cortex produces a response in a
targeted muscle, and the amplitude of this twitch provides an indirect measure of the
current state of the cortex. When applied to the motor cortex, rTMS can alter MEP
amplitude, however, results are variable between participants and across studies. In
addition, the mechanisms underlying any change and its locus are poorly understood. In
order to better understand these effects, MEPs have been investigated in vivo in animal
models, primarily in rats. One major difference in protocols between rats and humans
is the use of general anesthesia in animal experiments. Anesthetics are known to affect
plasticity-like mechanisms and so may contaminate the effects of an rTMS protocol. In
the present study, we explored the effect of anesthetic on MEP amplitude, recorded
before and after intermittent theta burst stimulation (iTBS), a patterned rTMS protocol
with reported facilitatory effects. MEPs were assessed in the brachioradialis muscle of
the upper forelimb under two anesthetics: a xylazine/zoletil combination and urethane.
We found MEPs could be induced under both anesthetics, with no differences in the
resting motor threshold or the average baseline amplitudes. However, MEPs were highly
variable between animals under both anesthetics, with the xylazine/zoletil combination
showing higher variability and most prominently a rise in amplitude across the baseline
recording period. Interestingly, application of iTBS did not facilitate MEP amplitude under
either anesthetic condition. Although it is important to underpin human application of
TMS with mechanistic examination of effects in animals, caution must be taken when
selecting an anesthetic and in interpreting results during prolonged TMS recording.
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INTRODUCTION
Transcranial magnetic stimulation is a technique which exploits
Faraday’s law of electromagnetic induction to induce a current
in the brain using a magnetic field generated by a coil. This
technique is applied either as a single pulse, in order to transiently
depolarize an underlying area of neural tissue, or repetitively,
where pulses are delivered with a defined frequency and pattern.
There has been increasing interest in the application of repetitive
transcranial magnetic stimulation (rTMS) because of its potential
to alter corticospinal excitability, namely the probability that cells
in a targeted area will fire in response to an excitatory input.
Such changes can be brought about through synaptic plasticity,
the ability of synaptic connections to either strengthen or weaken
in response to external or internal stimuli (Ho et al., 2011).
A major benefit of rTMS compared to traditional, electrical brain
stimulation is that it is non-invasive (Vallence and Ridding, 2014),
however, the mechanisms by which rTMS exerts its effect on the
brain are still poorly understood (Muller-Dahlhaus and Vlachos,
2013; Tang et al., 2015).
Clinically, rTMS has been applied as an experimental
treatment for a wide variety of neuropsychiatric and
neurophysiological disorders including stroke, depression,
and tinnitus, with variable effectiveness (Dell’osso et al., 2011;
Lefaucheur et al., 2014). The measured success of rTMS may
be due to the variety of potential rTMS stimulation parameters.
There are an unquantifiable number of possible combinations of
location, intensity, pattern, and duration of the stimulus train as
well as many possible configurations of the electromagnetic coil,
and we currently lack sufficient experimental data to understand
how these stimulation parameters map to outcomes in different
conditions. In the relatively short history of rTMS, it has broadly
been understood that low frequency rTMS (around 1 Hz) is
inhibitory (Chen et al., 1997) and higher frequencies appear
to be facilitatory (Fitzgerald et al., 2006; Ziemann et al., 2008),
although significant variation is reported. Attempts to improve
the strength and reproducibility of effects has led to recent
application of patterned stimulation protocols such as theta burst
stimulation (TBS) and quadripulse stimulation (QPS). These
protocols have shown some capacity to modulate corticospinal
excitability (Huang et al., 2005; Hamada et al., 2008), although
reproducing the effects originally reported with TBS has been
difficult (Brownjohn et al., 2014). Both TBS and QPS protocols
include variants that can putatively drive either facilitation
[such as intermittent TBS, intermittent theta burst stimulation
(iTBS); or 5 ms interstimulus interval QPS] or inhibition (such
as continuous TBS, cTBS; or 50 ms interstimulus interval
QPS).
In an effort to narrow the parameter space and maximize
the ability of rTMS protocols to induce plasticity of neural
responses, a variety of investigations have been made, primarily
by indirect means in humans but also more directly in animal
models. In humans, the efficacy of rTMS protocols is usually
measured by non-invasively stimulating the motor cortex with
single pulses of TMS, before and after an rTMS protocol,
and recording the motor evoked potential (MEP) from target
muscles using electromyography (EMG; Jennum et al., 1995; Di
Lazzaro et al., 2004). Changes in the amplitude of the MEP
after rTMS provide a measure of the change in excitability of
the polysynaptic neural pathway descending from the motor
cortex to the target muscle(s) (Fitzgerald et al., 2002; Huang
et al., 2005; Hamada et al., 2007). In contrast, studies of rTMS
effects in animal models have focused on cellular and molecular
markers of neuroplastic change rather than modulation of
MEPs (Gersner et al., 2011; Muller-Dahlhaus and Vlachos,
2013; Volz et al., 2013). This approach offers researchers the
chance to observe the direct effects of rTMS on stimulated
neurons and to understand the mechanisms through which
rTMS influences those neurons. However, despite significant
progress, how molecular changes measured very close to the
site of stimulation in animals relate to changes observed in
complex, polysynaptic MEPs measured in humans is as yet
unknown.
In order to bridge the gap in knowledge between single cell
and molecular changes measured in animals and network level
changes seen in humans, an interim step of correlating molecular
changes with MEPs recorded in animals may be of value. This
would enable meaningful comparison of protocols in animals
and humans that would support feedback between preclinical
testing and human research. However, unlike human studies,
MEPs in animal studies are often elicited under anesthesia
(Luft et al., 2001; Rotenberg et al., 2010; Hsieh et al., 2015)
because of practical difficulties with eliciting MEPs in awake
animals without significant restraint (Linden et al., 1999). It is
well known that different anesthesia compounds have differing
effects on cortical excitability, and so may impact on plasticity
induction by an rTMS protocol. However, with the exception of a
single study comparing pentobarbitone and a ketamine/xylazine
combination in rats (Vahabzadeh-Hagh et al., 2011), information
about the effects of different anesthetics on MEP amplitude and
resting motor threshold (RMT) is currently lacking. Before this
molecular-network gap can be bridged, then, it is necessary
to evaluate the effect these anesthetic compounds have on
MEPs.
In the present investigation we compared two injectable
rodent anesthetics, xylazine/zoletil, recently used by Hsieh et al.
(2015) to study the modulation of MEPs in rodents using iTBS,
and urethane, at doses our lab commonly uses to measure
synaptic plasticity in the brain (Reynolds et al., 2001, 2004;
Schulz et al., 2010). We compared how these agents influence
basic components of MEPs in rats and how they responded to
rTMS.
MATERIALS AND METHODS
Animal Preparation
Experiments were conducted on 27 Male Wistar rats (250–
350 g), sourced from the Hercus Taieri Resource Unit of the
University of Otago. All experiments and procedures were
approved by the Animal Ethics Committee of the University of
Otago (protocol number 77/13). Animals were group housed
in standard cages under a 12 h/12 h light-dark cycle. The
room was maintained at 22◦C with constant humidity. Water
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and food was available ad libitum between experimental
procedures.
On the day of recording, rats were deeply anesthetized with
either urethane (Sigma–Aldrich, New Zealand; 1600 mg/kg, I.P.;
n = 13) or a combination of xylazine (Bayer, New Zealand;
10 mg/kg, I.P) and zoletil (Zoletil 100, Virbac New Zealand;
80 mg/kg, I.P; n = 14). Anesthesia depth was monitored
periodically using the pedal withdrawal (“toe-pinch”) reflex at
the same relative timing and frequency in all animals. Absence
of the reflex indicated that a standardized depth of anesthesia
and analgesia was present and was maintained during electrode
implantation and recording. Increments of approximately 1/3
of the original dose of urethane or zoletil were given prior
to the commencement of recording to maintain the absence
of the pedal withdrawal reflex, i.e., the absence of any visible
movement in muscles in the lower leg, upper leg or abdomen
following the pedal stimulus (seen in approximately 50% of
animals at that stage). Pedal withdrawal was monitored in
this manner and remained absent prior to the commencement
of stimulation and after the baseline of MEPs was recorded.
The interval between application of additional anesthetic doses
and TMS measurements was comparable between the drugs:
51 ± 24 min for urethane (mean ± SD) and 38 ± 9 min
for zoletil (mean ± SD). There was no significant correlation
between the number of additional anesthetic doses given and
RMT (R2 = 0.1533, p > 0.05) or baseline MEP amplitude
(R2= 1.1× 10−6, p> 0.05). The pedal stimulus was administered
at least 1 min away from any TMS stimulation to avoid
inadvertent paired associative stimulation effects.
Temperature was maintained at 37◦C using a heating pad and
rectal thermometer. Rats were placed in a grounded stereotaxic
frame (Narishige, Japan) and electrically isolated from metal ear
bars using parafilm.
Electromyographic (EMG) Recording
To record MEPs, silver-wire electrodes were fashioned from 26
gage needles soldered to steel wire. These were placed in the
right brachioradialis muscle, located via palpation. Reference
electrodes were placed between the third and fourth digits
in the paw of the same forelimb. A ground electrode was
placed subcutaneously above the tail. The right forepaw was
immobilized using surgical tape adhered to the mat on which
the rats were placed. The signal was amplified 1000 times using
an Axoclamp900a (Molecular Devices, Sunnyvale, CA, USA),
digitized using a Digidata 1322a (Molecular Devices, Sunnyvale
CA, USA) and recorded using pClamp 10 software (Molecular
Devices, Sunnyvale CA, USA). The signal was sampled at 10 kHz
with no bandpass filtering. Successive MEPS were not excluded
on the basis of amplitude variability, however, episodes showing
a latency shorter than 4 ms were rejected (see Data Analysis).
To ensure stability of recording, interaction with the animal or
experimental set up was prohibited during active stimulation and
recording.
Transcranial Magnetic Stimulation
A 25 mm air-cooled figure-of-eight coil (Magstim) was placed
over the rat’s scalp and positioned to maximally activate the
underlying M1 area unilaterally. The center of the coil was
placed over the left motor cortex then rotated marginally in the
antero-posterior direction anti-clockwise in the same manner as
Rotenberg et al. (2010), in order to aid in producing MEPs with
maximum amplitude. The coil was powered by two Magstim
Rapid2 stimulators. Pulses were delivered at 0.2 Hz beginning
at ∼65% machine output to determine optimum stimulation
location, assessed by observing evoked responses. When coil
location was optimized, fine adjustment of electrode placement
was made, until a distinct MEP was observed. RMT was
determined by decreasing stimulator output by 5% until MEPs
vanished and then increasing in 1% increments until 6 MEPs of
≥50 µV peak to peak, were elicited out of every 12 TMS pulses.
20 min of baseline MEPS were recorded every 5 s (0.2 Hz) at 120%
of RMT.
Intermittent theta burst stimulation (X/Z n = 6; urethane
n = 7), or sham stimulation (X/Z n = 8; urethane n = 6) was
then applied for a total duration of 142 s. iTBS consists of a
burst of three pulses at 50 Hz, repeated at 5 Hz, delivered for
2 s with an 8 s off period (Huang et al., 2005). Four hundred
and fifty pulses were delivered based on previous data from our
lab using electrical iTBS which showed a change in synaptic
efficacy elicited using this protocol (Barry et al., 2014). rTMS
was delivered at 80% of RMT (up to 50% of machine output,
the maximum intensity the Rapid2 can deliver iTBS) for 450
pulses and a final 20 min of MEPs post stimulation recorded at
0.2 Hz at 120% RMT immediately after verum or sham treatment.
Sham stimulation was delivered by unplugging the verum coil
at the stimulator and plugging in another coil held at least
2 m from the rat head whilst the iTBS protocol was run, in
order to mimic auditory stimulation and maintain verum coil
positioning.
Data Analysis
All MEP data were analyzed oﬄine using Axograph X version
1.51. Each minute run was composed of 12 individual sweeps,
all of which were successful at evoking MEPs at 120% of
motor threshold, and amplitudes were measured from peak-to-
peak. For each animal, all data were normalized to the final
5 min of baseline amplitude recordings and expressed as a
percentage change, to allow for between-subject comparison.
Normalized amplitudes were then grouped into 2-min bins
and a final 3-min bin. Latencies were measured for each
sweep from the onset of the TMS artifact, and waveforms with
latencies < 4 ms were eliminated (∼30% of animals excluded).
These were excluded to ensure that any MEPs induced by
direct activation of the spinal circuitry by the coil were not
included in the analysis. Remaining traces in each minute
run were averaged and the peak-to-peak amplitude measured.
RMT and baseline amplitudes were compared between the two
groups using students unpaired t-tests. Data were determined
to be normally distributed by the D’Agostino-Pearson omnibus
normality test. Anesthetic and stimulation effects on normalized
amplitudes were compared using two-way repeated measures
ANOVA. All data were analyzed using Graphpad Prism 7
1www.axograph.com
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FIGURE 1 | Representative motor evoked potentials (MEP) traces recorded in animals anesthetized with (A) xylazine/zoletil or (B) urethane before (i)
and after (ii) intermittent theta burst stimulation (iTBS). Traces shown are an average of 12 sweeps. The dashed lines indicate points used for peak-to-peak
measurement of MEP amplitudes.
and expressed as mean ± standard deviation, unless otherwise
indicated.
RESULTS
Resting Motor Threshold and Baseline
Amplitude Measured in the
Brachioradialis Were Not Affected by
Anesthetic
Representative MEP traces evoked in animals under both
anesthetics can be seen in Figure 1. RMT (% of machine
output) was measured in the right brachioradialis muscle at
55.6% ± 10.0% for animals anesthetized with urethane (n = 9)
and for rats anesthetized with xylazine/zoletil 53.2% ± 10.4%
(n = 9; Figure 2A) (mean ± SD). Under the same conditions,
the baseline amplitudes from the final 5 min of the baseline
recording period were compared at a stimulus intensity of
120% machine output and measured as 316 ± 213 µV for
urethane and 475 ± 266 µV for xylazine/zoletil (Figure 2B).
There were no significant effects of anesthetic on RMT
(t16 = 0.48; p > 0.05) or baseline amplitude (t16 = 1.39;
p> 0.05).
MEP Amplitudes Increase across
Baseline Recording Period in Animals
Anesthetized with Xylazine/Zoletil But
Not Urethane
Responses recorded from animals anesthetized with
xylazine/zoletil increased in amplitude over the full baseline
recording period (Figure 3). This contrasted markedly to the
baseline responses evoked in urethane-anesthetized animals.
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FIGURE 2 | No differences were observed in resting motor threshold (RMT) (A) or baseline amplitude (B) in the MEPs recorded from the
brachioradialis muscle in rats anesthetized with urethane (n = 9) or xylazine/zoletil (n = 9). Baseline amplitude was averaged from MEPs recorded in final
5 min of pre-iTBS baseline. X/Z = xylazine/zoletil.
FIGURE 3 | The effect of anesthetic on MEP amplitude during the
baseline period. MEPs recorded from all animals anesthetized with
xylazine/zoletil (n = 9), showed increased amplitudes over the baseline
recording period, however, those from urethane anesthetized animals (n = 9)
remained stable. Data shown are mean ± SEM. Normalized amplitudes from
each minute are grouped into 2-min bins.
Two way ANOVA with repeated measures showed a significant
interaction (Greenhouse-Geisser corrected, F2,38 = 5.445;
p < 0.01), indicating that the amplitudes in the two groups
changed differently over time. A significant main effect of TIME
(Greenhouse-Geisser corrected, F2.3,38 = 8.1; p < 0.01) was also
revealed.
The effect of time between anesthetic dose and
commencement of recording (average of 43 min) on the stability
of MEP baselines was examined in the xylazine/zoletil group.
Linear regression showed no significant relationship between
this wait time and the slope of the normalized amplitudes of the
baseline recording in the same animal (F1,7 = 0.456, R2 = 0.061,
p> 0.05).
Intermittent Theta Burst Stimulation Did
Not Significantly Alter MEP Amplitudes
in Rats Anesthetized with
Xylazine/Zoletil or Urethane
Figure 4 shows the recordings made under each type of anesthetic
identified by whether iTBS (squares) or sham (circles) was the
protocol. Responses under xylazine/zoletil increased over the
baseline in all but one animal, and continued in many animals
following the protocol, regardless of whether administered iTBS
or sham stimulation (Figure 4A). The increasing baseline pattern
seemed to level off in a number of animals during the 10 min
following the protocol, giving the impression in a group-averaged
graph (Figure 5A) that MEPs were potentiated following the
baseline period, especially so when the baseline period was
truncated to 5 min preceding the protocol. In contrast, Figure 4B
shows the lack of systematic MEP baseline change under urethane
and the stable responses throughout both iTBS and sham under
this anesthetic (see group averaged responses in Figure 5B).
The fact that this was not due to the effects of TMS is
apparent when considering that the sham animals showed a
greater ‘pseudo potentiation’ effect under xylazine/zoletil than
those administered iTBS. Although the appearance is that iTBS
treatment transiently suppressed the rising baseline, data at these
points were not significantly different.
Statistical comparisons of the effects of the protocols on
animals under both anesthetics were performed using a two-
way ANOVA with repeated measures, with STIMULATION and
TIME as the factors. Under xylazine/zoletil anesthesia, there was
no significant difference as a result of TIME (Greenhouse-Geisser
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FIGURE 4 | Motor evoked potentials recorded from individual animals under each anesthetic, with both iTBS and sham animals shown together.
Variability between animals anesthetized with (A) xylazine/zoletil is greater than in animals anesthetized with (B) urethane. A rising amplitude over the baseline
recording period can be seen in most animals in (A). Two rats show a moderate rising amplitude whereas a single rat shows a falling baseline. Stimulated animals are
shown with squares; sham animals with filled circles. Dashed axis line indicates Sham or iTBS treatment (time point 0).
corrected, F2.5,17 = 0.69; p > 0.05) or TIME∗STIMULATION
interaction (Greenhouse-Geisser corrected, F2.5,17 = 0.69;
p > 0.05) (Figure 5A). Under urethane anesthesia there were no
significant differences as a result of TIME (Greenhouse-Geisser
corrected, F3.2,23 = 2.17; p > 0.05) or TIME∗STIMULATION
interaction (Greenhouse-Geisser corrected, F3.2,23 = 0.84;
p> 0.05).
DISCUSSION
With the widespread use of MEPs as a measure of efficacy in
human TMS studies, the present investigation aimed to explore
the effect of anesthetics on MEPs, as a potential complicating
variable in mechanistic studies performed on animals. We
compared two anesthetics, one that has been previously used
to study TMS modulation of MEPs in rodents, xylazine/zoletil
(Hsieh et al., 2015), and another that has frequently been
used to study the excitability of single neurons and synaptic
plasticity at monosynaptic connections, urethane (Reynolds and
Wickens, 2000; Clement et al., 2008; Parr-Brownlie et al., 2009;
Schulz et al., 2009; Wilson et al., 2010; Harris et al., 2014).
To our knowledge urethane has not been used to study TMS
effects on MEPs. We found that in animals anesthetized with
urethane, it was possible to elicit MEPs over an extended baseline
period, which remained stable. In contrast xylazine/zoletil,
under the same recording conditions and baseline duration,
showed a marked systematic baseline increase in responses.
With both agents, levels of anesthesia were adjusted in each
animal to the same suppression of peripheral responsiveness,
i.e., the absence of a pedal reflex. With both agents, there was
no induced modulation of MEP amplitudes when comparing
the effects of an iTBS rTMS protocol with a sham protocol.
However, there were marked qualitative differences in how
MEPs ‘responded’ following the baseline period under both
anesthetics.
Use of Anesthetics to Study Effects of
TMS in Animals
Characterization of the effect of neuroactive compounds on
TMS-evoked measures has been extensively discussed previously
(Ziemann et al., 2015). In humans, motor threshold is elevated
by sodium channel blockers (Ziemann et al., 1996; Boroojerdi
et al., 2001) as well as by certain NMDA-receptor antagonists
(Wohlfarth et al., 2000). Even markers of plasticity, such as BDNF,
are different after rTMS treatment in anesthetized vs. awake
animals (Gersner et al., 2011). Hence the decision to use an
anesthetic and the agent of choice must be carefully made, for the
results of TMS studies in animals to be generalized to humans.
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FIGURE 5 | Intermittent theta-burst stimulation did not significantly affect MEP amplitudes recorded in animals anesthetized with either (A)
xylazine/zoletil (iTBS = 5; Sham = 4) or (B) urethane (iTBS = 5; Sham = 4). Note the baseline data are truncated to 5 min preceding the protocols. All data
shown are mean ± SEM. Normalized amplitudes from each minute are grouped into 2-min bins. Dashed axis line indicates Sham or iTBS treatment (time point 0).
In studies using MEPs as a measure of cortical excitability in
rodents, anesthetics are frequently used, to avoid the neural and
systemic stress effects of restraint. In the few studies investigating
magnetically induced MEPs in animal models, there has been a
great variation in anesthetic choice. These range from inhalants
such as isoflurane and halothane (Luft et al., 2002; Deffeyes
et al., 2015; Vinit et al., 2016), and injectable anesthetics such
as sodium pentobarbital (Rotenberg et al., 2010; Vahabzadeh-
Hagh et al., 2011), and xylazine/zoletil (Hsieh et al., 2015). All
anesthetics are known to impact on neuronal function to varying
degrees, with their exact mechanisms of action altering how this
impact manifests (Angel and Gratton, 1982; Anis et al., 1983;
Simons et al., 1992; Lahti et al., 1999; Antkowiak, 2002; Antunes
et al., 2003). Xylazine, for example, is an α2-adrenoreceptor
agonist (Greene and Thurmon, 1988), primarily used for muscle
relaxation and sedation (Ko, 2013). It is also used in combination
with other compounds such as ketamine or zoletil (Ferrari
et al., 2005; Ko, 2013), because of its potentiating effects on
anesthetic and analgesic effects. When used in conjunction with
ketamine anesthesia, the effect is reportedly variable between
animals (Green et al., 1981; Smith, 1993). Zoletil is itself a mix of
tiletamine and zolazepam (Ko, 2013). Tiletamine is an NMDA-
receptor antagonist, chemically related to ketamine and acts
by fundamentally the same mechanisms, although it is more
potent. Zolazepam is a benzodiazepine, a positive modulator of
the GABA-A receptor, acting to decrease neuronal excitability
(Griffin et al., 2013). Action at the NMDA receptor might
potentially influence rTMS-induced cortical plasticity, which has
been shown to require NMDA activation (Huang et al., 2007;
Labedi et al., 2014). However, the demonstration of rTMS-
induced plasticity by Hsieh et al. (2015), namely potentiation of
MEPs after iTBS in healthy rats, has provided some evidence that
iTBS-induced facilitation is observable using xylazine/zoletil.
In contrast to the relatively targeted effects of xylazine/zoletil,
urethane is an anesthetic with non-specific actions potentially
affecting multiple neurotransmitter systems (Hara and Harris,
2002). Its use is restricted in many countries to non-survival
experiments, due to its prominent carcinogenic effects and long
duration of action. The most prominent effect on the nervous
system is a reduction of excitatory transmission with a minimal
enhancement or no effect on GABA transmission (Evans and
Smith, 1982; Dalo and Hackman, 2013). The main advantage of
the use of urethane in neural recording studies, is the duration
of anesthesia produced and the stability of anesthesia it induces.
Using electrical stimulation, we have previously observed clear
TBS-induced potentiation and depression of synaptic circuits
using urethane at the doses used here (Barry et al., 2014),
suggesting that urethane does not abolish the type of brain
plasticity likely to be observed following TBS applied with rTMS
(Maggi and Meli, 1986).
For the combination of zoletil with xylazine, previous
literature has suggested a range of 40–65 mg/kg for zoletil in
rats (Silverman et al., 1983; Ferrari et al., 2005). Anesthetic
duration has been suggested to last for anywhere from 1 to 4 h
in combination (Wilson et al., 1992; Ferrari et al., 2005). Using
65 mg/kg of zoletil and 10 mg/kg of xylazine for induction, Hsieh
et al. (2015) reported deep anesthesia for∼4 h. Interestingly, our
initial attempts at using 65 mg/kg zoletil with 10 mg/kg xylazine
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failed to bring rats to an adequate plane of anesthesia, resulting
in our application of a 20% greater dose of 80 mg/kg for zoletil.
This raises the possibility that differences in the level of animal
sedation between studies may have an impact on the size of
MEPs and also may critically influence the ability to induce MEP
plasticity using rTMS.
The Rise in MEP Amplitude during
Baseline Recording Period in
Xylazine/Zoletil Anesthetized Rats
During the baseline recording period, MEP amplitudes
consistently increased across time in rats anesthetized with
xylazine/zoletil. This effect was seen in the majority of animals
anesthetized with this agent combination, and contrasted with
urethane in the hands of the same experimenter, where MEP
amplitude remained relatively stable across the baseline. This
strongly suggests that the anesthetic agent was the underlying
cause. One possible mechanism of the increasing MEP baseline
amplitudes may be the actions and metabolism of the NMDA-
receptor antagonist component of zoletil, tiletamine. Metabolism
of tiletamine varies between species, with indications of a
half-life of 1 h in dogs and 2 h in cats (Ko, 2013), though
little information exists on the process in laboratory rodents.
In its zoletil form (given at up to 60 mg/kg), it induces a
maximum sleep time of just under 2 h in rats (Wilson et al.,
1992). At the concentrations used here, it is likely that the
tiletamine action initially elevate the RMT, defined earlier as
the stimulator output necessary to elicit MEPs >50 µVs, but
potentially this elevating effect may have reduced over time as
tiletamine was metabolized. With progressive attenuation of
the NMDA-receptor antagonism, physiological RMT would
have progressively decreased, manifesting as a slow increase in
MEP size. We also cannot exclude a contribution of the muscle
relaxant effect of xylazine wearing off. Xylazine was given as a
single dose, however, its half-life is up to 2–3 h (Garcia-Villar
et al., 1981; Veilleux-Lemieux et al., 2013). Since recordings were
completed by approx. 100 min after xylazine induction in all
animals, an effect on MEPs, if any, of metabolism of xylazine
would therefore more likely have occurred in the second half of
recording rather than during the baseline.
The sloping baseline MEP amplitude may also have been
influenced by the time between anesthetic injection and
commencement of the recording procedures. Hsieh et al. (2015)
did not report a sloping baseline and stated they waited 60 min
from injection to starting the recording experiment, whereas we
waited an average of 43 min following induction. Despite the
small difference between waiting 60 and 43 min, the additional
metabolism of tiletamine in that time may constitute a possible
reason for the disparities in the results of Hsieh and our own.
Linear regression showed no association between the baseline
slope of MEP amplitudes and the wait time for each animal.
These increases in MEP amplitudes also appear in all of the TBS-
exposed MEP recordings in Hsieh et al. (2015), however, the effect
is less dramatic, with only two baseline points shown. These data,
taken together, demonstrate the importance of applying protocols
that might modulate MEPs in anesthetized animals at a point
when all baseline anesthetic effects have stabilized, and to ensure
that all extended baseline data (beyond 10 min preceding the
protocol) are shown in these graphs.
Intermittent Theta Burst Stimulation Did
Not Affect MEP Amplitudes in Rats
Anesthetized with Xylazine/Zoletil or
Urethane
The present study failed to find any changes in MEP amplitude
after iTBS, in contrast to that reported by Hsieh et al. (2015)
under xylazine/zoletil anesthesia. In rats, iTBS has previously
been shown to induce changes in markers of inhibitory and
excitatory neuronal activity, as well as increases in the learning
rate in an associative tactile task (Mix et al., 2010; Hoppenrath
and Funke, 2013; Labedi et al., 2014). Changes in MEP amplitude
after iTBS have been demonstrated in humans (Huang et al.,
2005; Ziemann et al., 2008; Nettekoven et al., 2014), however,
to our knowledge have only been shown once in rats (Hsieh
et al., 2015). There are a few methodological differences between
the current study and that reported by Hsieh et al. (2015) that
may have contributed to the result, at least for our experiments
using xylazine and zoletil. Firstly, in our study we applied TBS
protocols using 450 pulses compared to the 600 pulses used
by Hsieh et al. (2015). This was based on our previous work
using urethane, where we showed clear differential synaptic
plasticity using 450 pulses applied using electrical stimulation
(Barry et al., 2014). Previous work in humans has shown that
variations in pulse number using the same rTMS protocol may
significantly affect the plasticity-inducing effects of those patterns
(Gamboa et al., 2010; Nettekoven et al., 2014). However, the effect
of increasing pulse number is usually manifest by an increase
in the duration of the after effects on MEPs rather than an
alteration in the degree of change, with even 300 pulses inducing
a significant effect on MEPs lasting for 20 min (Huang et al.,
2005). In addition, as described in the previous section, there
may have been a suppressive effect on baseline MEPs related to
the zoletil. However, even in individual experiments that showed
minimal sloping baseline effect, iTBS had no potentiating effect
that could be distinguished from sham animals. Though the
amount of xylazine/zoletil given in this study was quantitatively
higher, possibly indicating these rats were under a deeper level of
anesthesia, the same measures of anesthetic depth were used to
inform dose (i.e., pedal withdraw reflex). The fact that MEPs in
urethane-anesthetized rats showed a stable baseline but were not
affected by iTBS together raises the possibility that iTBS applied
using rTMS for 450 pulses does not produce any plastic responses
of MEPs, although this number of pulses applied electrically can
induce plasticity at synaptic connections in the brain (Barry et al.,
2014).
While we expected to demonstrate an effect of iTBS on MEPs
based on the findings of several human and animal experiments
with small numbers of participants, the lack of iTBS effects in
our study is in line with at least one study using larger numbers
of human participants. The first study to describe iTBS (and
cTBS) -evoked changes in MEPs (Huang et al., 2005) involved
nine participants in a repeated measures design. A larger study
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by Hamada et al. (2013) however, found that with many more
participants (n = 56), response to iTBS measured with MEPs
was extremely variable between subjects and the mean response
to iTBS across participants was essentially zero. A similar result
was reported by Lopez-Alonso using 56 subjects (Lopez-Alonso
et al., 2014). A recent paper (Héroux et al., 2015) reported
findings from a survey of 47 researchers who work with TMS.
They state that only 45% of those surveyed could reproduce the
original results using iTBS. Why there exists such a large inter-
individual variability in iTBS neuromodulation is still unknown,
but may be rooted in the sheer number of factors which influence
TMS-induced plasticity, such as genetics, age and circadian cycle
(Ridding and Ziemann, 2010; Hamada et al., 2013). Indeed,
Héroux noted that 70% of survey-responders reported knowing
colleagues who screened subjects according to some of the factors
known to affect rTMS-induced plasticity to increase chances of
responding favorably to stimulation protocols.
CONCLUSION
We have demonstrated in this study that a xylazine/zoletil
anesthetic combination induces a rising baseline in MEP
amplitude, potentially related to the metabolism of the
compounds. In designing any animal study, care should be taken
with anesthetic choice and adequate levels of sedation in order
to limit the often multi-factorial effects these agents have on
plasticity. Additionally, this study highlights and reconfirms the
variability of stimulation protocols, in this case iTBS, something
reported more often now in the human literature.
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